Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CryMed Technologies is a medical device company specializing in targeted cryotherapy solutions for oncology supportive care. The company's flagship product is a proprietary oral cryotherapy device designed to prevent and mitigate oral mucositis, a painful and common side effect in patients undergoing chemotherapy or radiation. Unlike traditional methods such as chewing on ice chips, CryMed's technology provides controlled and uniform cooling to the oral cavity to induce local vasoconstriction. This physiological response reduces the delivery of cytotoxic agents to the oral mucosal tissues, thereby protecting them from damage. Headquartered in New Jersey, the company focuses on improving the quality of life and treatment adherence for cancer patients through innovative thermal management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CryMed Technologies.